Bse SmallCap

Zuari Agro Chemicals has informed that in terms of Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled on Friday, 31st July, 2026 to consider the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2026. The Trading Window will continue to remain closed till 2nd August, 2026 i.e. 48 hours after the declaration of Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2026. The intimation is also being uploaded on the Company’s website at www.zuari.in.

The above information is a part of company’s filings submitted to BSE.

Shyam Metalics and Energy has informed that the Board of Directors of Shyam Metalics and Energy at its meeting held today, 20th July, 2026 considered and approved; The Unaudited Financial Results (Standalone and Consolidated) of the Company for the First Quarter ended June 30, 2026, duly reviewed and recommended by the Audit Committee along with Limited Review Report as issued by MSKA & Associates LLP, Chartered Accountants, the Statutory Auditors of the Company. The same is enclosed as Annexure-B. A copy of the said results together with the Limited Review Report for First Quarter ended June 30, 2026 are enclosed. These are also being made available on the website of the Company at www.shyammetalics.com;. The payment of 1st Interim Dividend of Rs 1.80/- per Equity Share, being 18% of the face value of Rs. 10/- each, for the financial year 2026-27. The Record Date for the purpose of determining entitlement of the members for the payment of Interim Dividend shall be Friday, 24 July, 2026. The payment of the said Interim Dividend shall be made within 30 days from the date of declaration; Fund Raising The raising of funds for an aggregate amount of up to ₹4,500 crore (Rupees Four Thousand Five Hundred Crore only), by way of issuance of equity shares, eligible securities, and/or any other equity-linked instruments, including convertible or nonconvertible preference shares, or fully/partly convertible debentures. The proposed issuance may be executed in one or more tranches through permissible routes under applicable laws, including a private placement (including one or more Qualified Institutions Placements 'QIP'), further public offering (FPO), preferential issue, or any combination thereof, for cash and at such premium or discount as may be considered appropriate by the Board or a duly constituted committee of the Board in accordance with applicable laws and permitted under regulatory guidelines.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Science has informed that the 35th Annual General Meeting ('AGM') of the Company will be held on Friday, August 14, 2026 at 12:15 hrs IST through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM'), in compliance with the applicable circulars issued by the Ministry of Corporate Affairs ('MCA') and the Securities and Exchange Board of India ('SEBI'). As intimated earlier, Board of Directors of the Company at their meeting held on May 18, 2026 had recommended a Final Dividend of ₹5/- per equity share of face value ₹10/- each (50%) for the financial year ended March 31, 2026, subject to approval of the shareholders at the ensuing AGM. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, July 31, 2026 as the Record Date for determining the entitlement of shareholders to receive the aforesaid Final Dividend: Final Dividend, if approved by shareholders at the ensuing AGM, shall be paid within 30 days from the date of its declaration, through permissible electronic modes to those shareholders whose bank account details are registered with the Depositories and/ or the Company's Registrar and Share Transfer Agent ('RTA'), subject to deduction of applicable taxes at source. Notice convening the AGM and the Annual Report for FY 2025-26 shall be filed separately with the Stock Exchanges and circulated to the shareholders within the prescribed timelines. The same shall also be made available on the website of the Company at www.strides.com and on the websites of BSE Limited and National Stock Exchange of India.

The above information is a part of company’s filings submitted to BSE.

Allcargo Logistics has informed that the meeting of the Board of Directors of the Company will be held on Wednesday, August 05, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended on June 30, 2026. The aforesaid information shall be made available on the Company's website at www.allcargologistics.com.

The above information is a part of company’s filings submitted to BSE.